AFT Forsyth & Company’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-3,518
Closed -$225K 129
2023
Q2
$225K Buy
3,518
+101
+3% +$6.77K 0.16% 124
2023
Q1
$237K Sell
3,417
-229
-6% -$16.2K 0.18% 122
2022
Q4
$262K Sell
3,646
-80
-2% -$6.03K 0.22% 115
2022
Q3
$265K Buy
3,726
+1
+0% +$73 0.24% 113
2022
Q2
$287K Hold
3,725
0.23% 109
2022
Q1
$272K Buy
3,725
+1
+0% +$67 0.17% 127
2021
Q4
$232K Sell
3,724
-499
-12% -$29.3K 0.12% 143
2021
Q3
$250K Hold
4,223
0.13% 138
2021
Q2
$282K Buy
4,223
+1
+0% +$65 0.15% 136
2021
Q1
$267K Sell
4,222
-148
-3% -$9.21K 0.16% 131
2020
Q4
$271K Sell
4,370
-71
-2% -$4.37K 0.17% 129
2020
Q3
$268K Buy
4,441
+618
+16% +$37.2K 0.2% 115
2020
Q2
$225K Buy
+3,823
New +$229K 0.19% 116
2020
Q1
Sell
-3,208
Closed -$206K 126
2019
Q4
$206K Buy
+3,208
New +$184K 0.16% 135
2018
Q4
Sell
-3,440
Closed -$214K 137
2018
Q3
$214K Buy
+3,440
New +$204K 0.18% 133
2018
Q2
Sell
-3,525
Closed -$223K 140
2018
Q1
$223K Sell
3,525
-2,425
-41% -$156K 0.21% 127
2017
Q4
$365K Buy
+5,950
New +$372K 0.36% 97
2013
Q3
$717K Buy
15,494
+700
+5% +$30.7K 0.93% 31
2013
Q2
$661K Buy
+14,794
New +$642K 0.94% 34

Other funds holding BMY

AFT Forsyth & Company's BMY Position: Q3 2023 in Review

AFT Forsyth & Company sold out of Bristol-Myers Squibb (BMY) in Q3 2023, closing a stake of 3,518 shares — an estimated $225K sold.

AFT Forsyth & Company first reported a position in BMY in Q2 2013 and held it in 19 quarters. The position peaked at $717K in Q3 2013. 2,388 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

  • AFT Forsyth & Company reported no remaining Bristol-Myers Squibb position as of Q3 2023 after selling out during the quarter.
  • AFT Forsyth & Company sold 3,518 Bristol-Myers Squibb shares in Q3 2023, an estimated $225K.
  • AFT Forsyth & Company first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 19 quarters.
  • AFT Forsyth & Company's Bristol-Myers Squibb position peaked at $717K in Q3 2013.
  • 2,388 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on AFT Forsyth & Company's 13F filing for Q3 2023, filed 7 Nov 2023.